Revista de gastroenterologia de Mexico (English)最新文献

{"title":"Impact of biofeedback therapy in constipation due to dyssynergic defecation","authors":"A. Fuentes-Montalvo, A.L. Ordóñez-Vázquez, J.S. Arenas-Martínez, E. Coss-Adame","doi":"10.1016/j.rgmxen.2024.08.008","DOIUrl":"10.1016/j.rgmxen.2024.08.008","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 2","pages":"Pages 311-313"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144227811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preoperative management of patients receiving treatment with GLP-1 analogues: Withhold or individualize?","authors":"J. Crespo, P. Iruzubieta","doi":"10.1016/j.rgmxen.2024.11.007","DOIUrl":"10.1016/j.rgmxen.2024.11.007","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 2","pages":"Pages 344-345"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to Hinpetch Daungsupawong et al. regarding “Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown: Correspondence”","authors":"F. Higuera-de-la-Tijera, F. Lajud-Barquín, A. Tovar-Aguilar","doi":"10.1016/j.rgmxen.2025.01.004","DOIUrl":"10.1016/j.rgmxen.2025.01.004","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 2","pages":"Pages 339-341"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validation of the animal naming test for diagnosing minimal hepatic encephalopathy","authors":"A.D. Cano-Contreras ,&nbsp;J.A. Velarde-Ruiz Velasco ,&nbsp;F. Higuera-de-la-Tijera ,&nbsp;C.F. Castillo-Diaz ,&nbsp;D. Grajales-Velázquez ,&nbsp;I. Méndez-Ruiz ,&nbsp;V.A. Jiménez-Hernández ,&nbsp;R. Aguirre-Lázaro ,&nbsp;J.A. Sánchez-Hernández ,&nbsp;H.R. Ordaz-Álvarez ,&nbsp;J.M. Remes-Troche","doi":"10.1016/j.rgmxen.2025.05.003","DOIUrl":"10.1016/j.rgmxen.2025.05.003","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>The diagnosis of minimal hepatic encephalopathy (MHE) is complex in clinical practice, given that its adequate evaluation is time-consuming. The animal naming test (ANT1) has proven to be a useful tool for rapid MHE identification. Our aim was to validate the ANT1 in a cohort of Mexican patients with cirrhosis of the liver.</div></div><div><h3>Material and methods</h3><div>An observational, cross-sectional, and analytic study was conducted within the time frame of June 2022 and May 2023. MHE diagnosis was made using the psychometric hepatic encephalopathy score (PHES). Patients with overt HE evaluated through the West Haven criteria were excluded. The ANT1 was performed on all participants.</div></div><div><h3>Results</h3><div>A total of 199 patients with cirrhosis and 31 non-cirrhotic control subjects were analyzed. Women predominated (61.8% and 71%) and mean patient age was 55 ± 10 and 53.6 ± 12 (range 19–84 years), respectively. Ninety patients (45.2%) met the MHE criteria determined by the PHES. Using an ANT1 cutoff point of ≤15, MHE was identified in 65 (32.7%) patients, along with 75% sensitivity, 72% specificity, 53% positive predictive value, 87% negative predictive value, and 73% diagnostic accuracy. The area under the curve for diagnosing MHE was 0.763 (standard error, 0.081; 95% confidence interval, 0.604−0.923; p ≤ 0.0001).</div></div><div><h3>Conclusions</h3><div>The ANT1 was shown to be a useful tool for identifying MHE in daily clinical practice. In our population, a cutoff point ≤15 animals named could be utilized for rapid screening of patients at high risk for progressing to overt HE, who would then require extensive testing.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 2","pages":"Pages 192-198"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144227812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hemostatic powder efficacy for the endoscopic management of malignant upper gastrointestinal bleeding","authors":"J.P. Pérez-Macías,&nbsp;M.E. Ramírez-Solís,&nbsp;A.I. Hernández-Guerrero,&nbsp;J.G. Dela Mora-Levy,&nbsp;W.D. Torrecilla-Ramírez,&nbsp;B.A. Sánchez-Jiménez,&nbsp;G.M. Salgado-Castellón","doi":"10.1016/j.rgmxen.2024.10.011","DOIUrl":"10.1016/j.rgmxen.2024.10.011","url":null,"abstract":"<div><h3>Introduction</h3><div>Upper gastrointestinal bleeding (UGIB) of neoplastic origin is a rare but life-threatening cause of bleeding. Endoscopic treatment is challenging due to diffuse oozing blood and high rates of rebleeding, despite coagulation and hemoclip use. Hemostatic powders can be an option in those patients. We aimed to determine the initial hemostatic rate and the rebleeding rate at 7 and 30 days, using hemostatic powders in patients with malignant UGIB at a national referral center in Mexico.</div></div><div><h3>Material and methods</h3><div>A retrospective, observational study was conducted on patients with malignant UGIB treated with hemostatic powder between 2018-2023. Demographic and clinical variables, endoscopic findings, and treatment results were analyzed. A central tendency analysis and the chi-square test were employed.</div></div><div><h3>Results</h3><div>The study included 54 patients (54.7% were men), with a mean age of 54 years. A total of 40.7% were diagnosed with gastric cancer and presented with an episode of malignant UGIB. Of the endoscopic findings, 52% of patients had active malignant UGIB, most presenting with oozing bleeding (57.4%). EndoClot™ was the main monotherapy employed (81.5%), achieving initial homeostasis in 100% of cases. The rebleeding rate was 22.2% at 7 days and 44.4% at 30 days, with a 30-day accumulated mortality rate of 35.2%.</div></div><div><h3>Conclusions</h3><div>Malignant UGIB is a potentially life-threatening complication. Hemostatic powder use is highly recommendable due to its efficacy in the immediate control of bleeding. Nevertheless, its effect is temporary, suggesting its use as bridging therapy, facilitating bleeding stabilization and enabling the implementation of definitive hemostatic treatments.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 2","pages":"Pages 199-206"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Good clinical practice recommendations for proton pump inhibitor prescription and deprescription. A review by experts from the AMG","authors":"L.R. Valdovinos-García ,&nbsp;A.S. Villar-Chávez ,&nbsp;F.M Huerta-Iga ,&nbsp;M. Amieva-Balmori ,&nbsp;J.S. Arenas-Martínez ,&nbsp;R. Bernal-Reyes ,&nbsp;E. Coss-Adame ,&nbsp;O. Gómez-Escudero ,&nbsp;P.C. Gómez-Castaños ,&nbsp;M. González-Martínez ,&nbsp;E.C Morel-Cerda ,&nbsp;J.M. Remes-Troche ,&nbsp;M.C. Rodríguez-Leal ,&nbsp;D. Ruiz-Romero ,&nbsp;M.A. Valdovinos-Diaz ,&nbsp;G. Vázquez-Elizondo ,&nbsp;J.A. Velarde-Ruiz Velasco ,&nbsp;M.R. Zavala-Solares","doi":"10.1016/j.rgmxen.2024.11.002","DOIUrl":"10.1016/j.rgmxen.2024.11.002","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>Proton pump inhibitors (PPIs) are widely known drugs that are used quite frequently and indicated in both the short and long terms, in numerous acid-related diseases. Our aim was to produce an expert review that establishes recommendations for the adequate prescription and deprescription of PPIs.</div></div><div><h3>Methods</h3><div>A group of experts in PPI use that are members of the <em>Asociación Mexicana de Gastroenterología</em> (<em>AMG</em>), after extensively reviewing the published literature and discussing each recommendation at a face-to-face meeting, prepared the present document of good clinical practice recommendations. This document is not intended to be a clinical practice guideline or utilize the methodology said format requires.</div></div><div><h3>Results</h3><div>Eighteen experts on PPI use developed 22 good clinical practice recommendations for prescribing short-term, long-term, and on-demand PPIs, recognizing adverse events, and lastly, deprescribing PPIs, in acid-related diseases.</div></div><div><h3>Conclusions</h3><div>At present, there is scientific evidence on PPI use in numerous diseases, some in the short term (4-8 weeks), others on-demand (for short periods until symptoms improve), or in the long term (without suspending). Numerous adverse effects have been attributed to PPIs, but the majority have no well-established causal association. Nevertheless, PPIs should be suspended when there is no clear indication for their use. These recommendations aim to aid general physicians and specialists, with respect to PPI prescription and deprescription.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 111-130"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Eosinophilic esophagitis: Current state and perspectives in Latin America","authors":"D. García-Compeán","doi":"10.1016/j.rgmxen.2024.09.003","DOIUrl":"10.1016/j.rgmxen.2024.09.003","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 4-7"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endoluminal vacuum therapy for the management of acute mediastinitis following esophagogastrectomy: Case report of a patient with esophageal adenocarcinoma","authors":"G.K. Casadiego,&nbsp;C. Rojas,&nbsp;S. Prado,&nbsp;E. de la Fuente","doi":"10.1016/j.rgmxen.2024.08.004","DOIUrl":"10.1016/j.rgmxen.2024.08.004","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 143-146"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143912311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factor XI/XIa inhibitors for splanchnic vein thrombosis associated with liver cirrhosis: Is there any potential role?","authors":"M. Porres-Aguilar ,&nbsp;W. Ageno ,&nbsp;M. Uribe","doi":"10.1016/j.rgmxen.2024.08.007","DOIUrl":"10.1016/j.rgmxen.2024.08.007","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 165-166"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An App model that utilizes a logistic regression algorithm for predicting choledocholithiasis: A prospective clinical trial","authors":"F. García-Villarreal ,&nbsp;L.M. Torres-Treviño ,&nbsp;C. Herrera-Figueroa ,&nbsp;J.O. Jáquez-Quintana ,&nbsp;A.A. Garza-Galindo ,&nbsp;C.A. Cortez-Hernández ,&nbsp;D. García-Compeán ,&nbsp;R.A. Jiménez-Castillo ,&nbsp;H.J. Maldonado-Garza ,&nbsp;J.A. González-González","doi":"10.1016/j.rgmxen.2024.05.007","DOIUrl":"10.1016/j.rgmxen.2024.05.007","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>The diagnostic yield of the current criteria for assigning the risk of choledocholithiasis (CL) is inaccurate. The aim of our work was to develop a logistic regression model for predicting CL diagnosis in patients catalogued as either intermediate or high risk for CL, according to the criteria of the American Society for Gastrointestinal Endoscopy (ASGE).</div></div><div><h3>Material and methods</h3><div>We conducted an analytic, observational, cross-sectional study for evaluating the diagnostic yield of a logistic regression model in adults with intermediate or high risk for CL. A receiver operating characteristic (ROC) curve analysis was done to determine the best cutoff point for predicting the diagnosis of CL. Endoscopic retrograde cholangiopancreatography (ERCP) was utilized as the gold standard for diagnosing CL.</div></div><div><h3>Results</h3><div>A total of 148 patients suspected of presenting with CL were studied. In our cohort, 71 had immediate risk and 77 had high risk. CL diagnosis was confirmed in 102 patients (69%). Our model showed an area under the curve (AUC) of 0.68. In patients with an intermediate risk for CL, the AUC value was 0.72 and the positive predictive value (PPV) was 70%. In patients with a high risk for CL, the AUC value was 0.78 and the PPV was 89%.</div></div><div><h3>Conclusion</h3><div>Our model appears to better predict the diagnosis of CL than the ASGE criteria for patients with an intermediate or high risk for the disease. Our model can guide clinical decisions in patients with suspected CL.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 22-28"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}